Doxyrazole 60 mg 14 capsules

Tradename

Doxyrazole

Composition

Each capsule contains:

Dexlansoprazole 60 mg

Auxiliary components:

magnesium carbonate, sucrose, lowsubstitutedhyprolose, hyprolose, hypromellose, talc, titanium dioxide (E 171), methacrylic acid copolymer, macrogol 8000, polysorbate 80, anhydrous colloidal silicon dioxide, gelatin.

Properties

Dexlansoprazole is a proton pump inhibitor (PPI), suppressing gastric acid secretion by inhibiting H + / K + -AT Pase in the parietal cells of the stomach. Blocks the final stage of hydrochloric acid secretion.

Indications

-treatment of erosive esophagitis of any severity;

— supportive therapy after treatment of erosive esophagitis and relief of heartburn;

-symptomatic treatment of gastroesophageal reflux disease (GERD, including NERD — non-

Contraindications

hypersensitivity to any component of the drug;

-cooperative use with inhibitors of HIV proteases, the absorption of which depends on the pH of the stomach environment (such as atazanavir, nelfinavir), due to a significant decrease in their bioavailability;

-pregnancy;

Side effects

From the gastrointestinal tract: often diarrhea, discomfort and abdominal pain, constipation, flatulence, nausea; infrequently dry mouth, vomiting; rarely — oral candidiasis; frequency unknown — edema of the oral mucosa, pancreatitis.

From the liver and biliary tract: infrequently change in the indicators of the functional activity of the liver; frequency unknown — drug hepatitis.

Skin and subcutaneous tissue disorders: infrequently — rash, hives, itching; frequency unknown — leukocytoclastic vasculitis, generalized rash, subacute cutaneous lupus erythematosus.